Studying the effect of combination topical therapy using three medications (Dorzolamide drops, Ketorolac drops, Prednisolone drops) in treatment of Ivrin Gass syndrome (CME) post cataract surgery
Phase 2
- Conditions
- Macular edema after uncomplicated cataract surgery.
- Registration Number
- IRCT20210519051344N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patient with CME after uncomplicated cataract surgery
completing informed consent form to participate in the study
Exclusion Criteria
Patients with diabetic retinopathy,
retinal and vascular patients,
patients with macular
Patients with severe renal insufficiency, hepatic insufficiency, etc. are excluded from the study.degeneration are excluded from the study to control confounding variables. All patients admitted to the study can withdraw from the study at any time from the start of the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Macular thickness. Timepoint: Treatment will continue for up to 2 months after starting treatment. If CME improves before this time, the patient will be examined for up to 8 weeks. The studied variables were patient vision before starting and 2, 4, 8 weeks after starting treatment, IOP before starting and 2, 4, 8 weeks after starting treatment and macular thickness before starting treatment and 2, 4 and 8 weeks after From the beginning of treatment. Method of measurement: Oct device and Goldman tonometer.
- Secondary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: Treatment will continue for up to 2 months after starting treatment. If CME improves before this time, the patient will be examined for up to 8 weeks. The studied variables were patient vision before starting and 2, 4, 8 weeks after starting treatment, IOP before starting and 2, 4, 8 weeks after starting treatment and macular thickness before starting treatment and 2, 4 and 8 weeks after From the beginning of treatment. Method of measurement: Goldman Tonometer.